we studied the effect of nafazatrom on plasma prostacyclin ( pgi2 ) levels , platelet function , and thromboxane b2 ( txb2 ) , and 12-hydroxy-eicosatetraenoic acid ( 12-hete ) production and clinical improvement in 12 patients with peripheral vascular disease ( pvd ) by means of a double-blind crossover trial of placebo , 800 or 1600 mg of nafazatrom four times daily for 1 week , with intervening 2-week washout periods .
C0033567
pgi2
C0085096
peripheral vascular disease